Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Injections × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 33 Breast Neoplasms 17 Advanced Solid Tumors 15 Myelodysplastic Syndromes 14 Advanced Solid Tumor 10 Recurrence 9 Carcinoma, Non-Small-Cell Lung 9 Leukemia, Myelomonocytic, Chronic 8 Neoplasms 7 Myeloproliferative Disorders 6 Lymphoma, Large B-Cell, Diffuse 6 Solid Tumor 5 Ovarian Neoplasms 5 Multiple Myeloma 5 Advanced Solid Tumour 5 Pancreatic Neoplasms 4 Lymphoma, B-Cell 4 Lung Neoplasms 4 Carcinoma, Hepatocellular 4 Triple Negative Breast Neoplasms 3 Stomach Neoplasms 3 Sarcoma 3 Primary Myelofibrosis 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neuroendocrine Tumors 3 Neoplasm Metastasis 3 Myelodysplastic-Myeloproliferative Diseases 3 Leukemia, Monocytic, Acute 3 Fallopian Tube Neoplasms 3 Colorectal Neoplasms 3

Interventions

pembrolizumab 35 enfortumab vedotin 17 Gemcitabine 17 Nivolumab 15 Cisplatin 14 avelumab 13 Magnetic Resonance Spectroscopy 13 atezolizumab 12 Carboplatin 11 Specimen Handling 9 Docetaxel 9 sacituzumab govitecan 8 Ipilimumab 7 Paclitaxel 5 Fluorodeoxyglucose F18 5 pemigatinib 4 toripalimab 3 durvalumab 3 cabozantinib 3 X-Rays 3 Mitomycin 3 Immunoglobulin G 3 CTLA-4 Antigen 3 Biopsy 3 tislelizumab 2 lenvatinib 2 erdafitinib 2 dodecyl maltoside 2 Platinum 2 FAPI-46 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡